International Symposium on the Treatment of Carcinoma of the Prostate, Berlin, November 13 to 15, 1969. Life Science Monographs

Content: 
Front Matter, Page iii
Copyright, Page iv
Introductions, Page 1, W. Brosig, W.E. Goodwin
Basis of Hormonal Treatment of Prostatic Cancer, Pages 3-7, C.V. Hodges
Hormonal Treatment of Cancer of the Prostate Pharmacological Aspects, Pages 9-22, R.R. Salloch, F. Neumann, M. Kramer
The Metabolism of Testosterone in the Prostate, Pages 23-30, D.C. Williams
Pharmacological Aspects on the Treatment of Prostatic Carcinoma with Stilbestrol Diphosphate, Pages 31-39, N. Brock
Pathology of Cancer of Prostate, Pages 41-64, F.K. Mostofi
The Incidence of Cardiovascular Complications in Prostatic Cancer, Pages 65-80, G.T. Mellinger, C. Blackard
Methods of Hormonal Treatment including Orchiectomy and Adrenalectomy, Pages 81-91, W.W. Scott
Total Perineal Prostatectomy in 398 Patients with Cancer of the Prostate, Pages 93-110, E. Belt, F.H. Schröder
Modern Radiotherapy of Prostatic Cancer, Pages 111-123, M.A. Bagshaw
The Use of Radioactive Isotopes in the Management of Prostatic Cancer, Pages 125-140, R.H. Flocks
Irradiation of the Hypophysis for advanced Cancer of the Prostate with Metastases, Pages 141-144, J.D. Fergusson
Cytotoxic Agents in the Treatment of Prostatic Carcinoma, Pages 145-159, G. Jönsson
Cyproterone Acetate Treatment of Disseminated Prostatic Cancer and Benign Nodular Hyperplasia, Pages 161-163, W.W. Scott
Treatment of Benign Prostatic Hypertrophy with Progestogens including Gestonorone Caproate, Pages 165-182, R. Nagel
Panel Discussion, Pages 183-205, H. Brendler, W. Brosig, R.H. Flocks, C.V. Hodges, J.J. Kaufman, G.T. Mellinger, W.W. Scott
Closing Addresses, Page 206, W. Brosig, H. Brendler
Participants, Pages 207-209
Name Index, Page ibc1
Advances in the Biosciences, Pages ibc2-ibc3